<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang L</submitter><funding>Medical Vertical Project of Fujian Province</funding><funding>Key Project of Natural Science Foundation of Fujian Provinc</funding><pagination>e0277006</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9970063</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(2)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Cysteine Protease Inhibitor 1 (CST1), a cystatin superfamily protein with the effect on the inhibition of cysteine protease activity, is reported to be involved in the development of many malignancies. MiR-942-5p has been demonstrated its regulatory effects on some malignancies. However, the roles of CST1 and miR-942-5p on esophageal squamous cell carcinoma (ESCC) are still unknown up to now.&lt;h4>Methods&lt;/h4>The expression of CST1 in ESCC tissues was analyzed by TCGA database, immunohistochemistry, and RT-qPCR, respectively. Matrigel-uncoated or-coated transwell assay was used to determine the effect of CST1 on migration and invasion of ESCC cells. Regulatory effect of miR-942-5p on CST1 was detected by dual luciferase assay.&lt;h4>Results&lt;/h4>CST1 was ectopically highly expressed in ESCC tissues, and had the effect on promoting the migration and invasion of ESCC cells by upregulating phosphorylated levels of key effectors including MEK1/2, ERK1/2, and CREB in MEK/ERK/CREB pathway. Dual-luciferase assay results showed that miR-942-5p had a regulatory effect on targeting CST1.&lt;h4>Conclusions&lt;/h4>CST1 plays a carcinogenic role on ESCC, and miR-942-5p can regulate the migration and invasion of ESCC cells by targeting CST1 to downregulate MEK/ERK/CREB signaling pathway, suggesting that miR-942-5p/CST1 axis might be a promising target for diagnosis and treatment of ESCC.</pubmed_abstract><journal>PloS one</journal><pubmed_title>MiR-942-5p inhibits tumor migration and invasion through targeting CST1 in esophageal squamous cell carcinoma.</pubmed_title><pmcid>PMC9970063</pmcid><funding_grant_id>2022J02048</funding_grant_id><funding_grant_id>2020CXB001</funding_grant_id><pubmed_authors>Pan X</pubmed_authors><pubmed_authors>Yin X</pubmed_authors><pubmed_authors>Yu L</pubmed_authors><pubmed_authors>Huang Y</pubmed_authors><pubmed_authors>Yu S</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Tu M</pubmed_authors><pubmed_authors>Cai L</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors></additional><is_claimable>false</is_claimable><name>MiR-942-5p inhibits tumor migration and invasion through targeting CST1 in esophageal squamous cell carcinoma.</name><description>&lt;h4>Introduction&lt;/h4>Cysteine Protease Inhibitor 1 (CST1), a cystatin superfamily protein with the effect on the inhibition of cysteine protease activity, is reported to be involved in the development of many malignancies. MiR-942-5p has been demonstrated its regulatory effects on some malignancies. However, the roles of CST1 and miR-942-5p on esophageal squamous cell carcinoma (ESCC) are still unknown up to now.&lt;h4>Methods&lt;/h4>The expression of CST1 in ESCC tissues was analyzed by TCGA database, immunohistochemistry, and RT-qPCR, respectively. Matrigel-uncoated or-coated transwell assay was used to determine the effect of CST1 on migration and invasion of ESCC cells. Regulatory effect of miR-942-5p on CST1 was detected by dual luciferase assay.&lt;h4>Results&lt;/h4>CST1 was ectopically highly expressed in ESCC tissues, and had the effect on promoting the migration and invasion of ESCC cells by upregulating phosphorylated levels of key effectors including MEK1/2, ERK1/2, and CREB in MEK/ERK/CREB pathway. Dual-luciferase assay results showed that miR-942-5p had a regulatory effect on targeting CST1.&lt;h4>Conclusions&lt;/h4>CST1 plays a carcinogenic role on ESCC, and miR-942-5p can regulate the migration and invasion of ESCC cells by targeting CST1 to downregulate MEK/ERK/CREB signaling pathway, suggesting that miR-942-5p/CST1 axis might be a promising target for diagnosis and treatment of ESCC.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2025-04-04T21:47:49.152Z</modification><creation>2025-04-04T21:47:49.152Z</creation></dates><accession>S-EPMC9970063</accession><cross_references><pubmed>36848349</pubmed><doi>10.1371/journal.pone.0277006</doi></cross_references></HashMap>